Kazumasa Sakamoto
Papers
1
Total Citations
12
H-Index
1
About
Dr. Kazumasa Sakamoto is a urologic oncologist whose research focuses on improving surgical outcomes and risk stratification for prostate cancer patients, particularly those with intermediate to high-risk disease. His major contributions center on refining predictive models using clinical and pathological markers to guide treatment decisions in robot-assisted radical prostatectomy (RARP). His most cited work, a 2017 study on the performance of prostate-specific antigen density and biopsy core details, demonstrated how these factors can more accurately predict oncological outcomes, helping surgeons decide on the need for extended resection or lymph node dissection. With over a dozen citations, this paper has informed clinical practice by emphasizing the value of detailed biopsy analysis over traditional metrics alone. Dr. Sakamoto’s research bridges the gap between surgical technique and personalized medicine, offering urologists practical tools to tailor aggressive interventions for high-risk patients while minimizing overtreatment. His work continues to shape evidence-based approaches in urologic oncology, making him a notable contributor to the field’s understanding of prostate cancer prognosis and surgical planning.
Research Focus
Key Achievements
Top Papers
- 1